id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-279294-ruqednj6	Lin, Dong D.	Chemotherapy Treatment Modifications During the COVID-19 Outbreak at a Community Cancer Center in New York City	2020-08-14		.txt	text/plain	3235	176	43	[8] [9] [10] The COVID-19 cases started to increase exponentially in New York City in early March, and we witnessed the fear and its impact on both patients with cancer and providers, who started to make recommendations on chemotherapy regimen modifications. The senior author (Y.X.) interviewed each of the five medical oncologists to gather the following information on every patient: cancer type; nature of treatment and status of disease: metastatic, adjuvant or primary treatment; treatment regimen; modification(s) made; who-provider or patient-initiated the modifications; and the reason for not offering modifications, if applicable. In the face of the coronavirus pandemic at a community cancer center in New York City, we wanted to know how often chemotherapy schedules were modified and what the key factors were that influenced the decision-making process. Overall, our study revealed that as many as 56.4% of all patients and approximately 40% of patients taking curative treatments received treatment modifications in the midst of the COVID-19 pandemic in our community cancer center.	./cache/cord-279294-ruqednj6.txt	./txt/cord-279294-ruqednj6.txt